Nomura Research Institute (NRILY)
(Delayed Data from OTC)
$36.96 USD
-0.49 (-1.31%)
Updated Sep 24, 2024 03:38 PM ET
1-Strong Buy of 5 1
F Value B Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for Nomura Research Institute falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,297 | 1,062 | 1,154 | 1,473 | 995 |
Receivables | 979 | 974 | 1,208 | 960 | 1,198 |
Notes Receivable | 0 | 0 | 0 | 0 | 14 |
Inventories | 0 | 0 | 0 | 0 | 24 |
Other Current Assets | 520 | 548 | 608 | 488 | 158 |
Total Current Assets | 2,796 | 2,583 | 2,969 | 2,921 | 2,388 |
Net Property & Equipment | 278 | 312 | 334 | 422 | 583 |
Investments & Advances | 625 | 595 | 673 | 588 | 325 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 42 | 42 | 48 | 48 | 64 |
Intangibles | 1,831 | 1,756 | 1,876 | 805 | 782 |
Deposits & Other Assets | 597 | 679 | 781 | 753 | 711 |
Total Assets | 6,367 | 6,203 | 7,028 | 5,930 | 4,854 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 61 |
Accounts Payable | 366 | 412 | 479 | 337 | 235 |
Current Portion Long-Term Debt | 91 | 150 | 1,041 | 215 | 47 |
Current Portion Capital Leases | 76 | 69 | 109 | 112 | 8 |
Accrued Expenses | 0 | 0 | 0 | 0 | 350 |
Income Taxes Payable | 165 | 97 | 184 | 81 | 191 |
Other Current Liabilities | 783 | 739 | 843 | 830 | 398 |
Total Current Liabilities | 1,481 | 1,467 | 2,655 | 1,575 | 1,291 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 109 | 104 | 91 | 22 | 17 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,752 | 1,352 | 812 | 846 | 838 |
Non-Current Capital Leases | 141 | 188 | 267 | 323 | 18 |
Other Non-Current Liabilities | 104 | 114 | 155 | 155 | 97 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,586 | 3,225 | 3,980 | 2,921 | 2,261 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 170 | 175 | 199 | 191 | 184 |
Capital Surplus | 217 | 218 | 252 | 241 | 148 |
Retained Earnings | 2,210 | 2,380 | 2,927 | 2,517 | 2,784 |
Other Equity | 304 | 251 | 283 | 196 | 88 |
Treasury Stock | 121 | 46 | 612 | 136 | 612 |
Total Shareholder's Equity | 2,781 | 2,978 | 3,048 | 3,010 | 2,593 |
Total Liabilities & Shareholder's Equity | 6,367 | 6,203 | 7,028 | 5,930 | 4,854 |
Total Common Equity | 2,781 | 2,978 | 3,048 | 3,010 | 2,593 |
Shares Outstanding | 580.80 | 593.60 | 610.70 | 610.00 | 694.00 |
Book Value Per Share | 4.79 | 5.02 | 4.99 | 4.93 | 3.74 |
Fiscal Year End for Nomura Research Institute falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 1,297 | 1,097 | 978 | 1,127 |
Receivables | NA | 979 | 646 | 787 | 0 |
Notes Receivable | NA | 0 | NA | NA | 713 |
Inventories | NA | 0 | NA | NA | 0 |
Other Current Assets | NA | 520 | 661 | 625 | 582 |
Total Current Assets | NA | 2,796 | 2,405 | 2,389 | 2,421 |
Net Property & Equipment | NA | 278 | 275 | 288 | 308 |
Investments & Advances | NA | 625 | 563 | 579 | 610 |
Other Non-Current Assets | NA | 0 | NA | NA | 0 |
Deferred Charges | NA | 42 | 38 | 41 | 43 |
Intangibles | NA | 1,831 | 1,759 | 1,787 | 1,848 |
Deposits & Other Assets | NA | 597 | 614 | 626 | 667 |
Total Assets | NA | 6,367 | 5,864 | 5,944 | 6,140 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | NA | NA | 0 |
Accounts Payable | NA | 366 | 205 | 257 | 275 |
Current Portion Long-Term Debt | NA | 91 | 107 | 238 | 121 |
Current Portion Capital Leases | NA | 76 | 75 | 79 | 80 |
Accrued Expenses | NA | 0 | NA | NA | 0 |
Income Taxes Payable | NA | 165 | 56 | 119 | 41 |
Other Current Liabilities | NA | 783 | 756 | 792 | 798 |
Total Current Liabilities | NA | 1,481 | 1,199 | 1,485 | 1,315 |
Mortgages | NA | 0 | NA | NA | 0 |
Deferred Taxes/Income | NA | 109 | 127 | 116 | 144 |
Convertible Debt | NA | 0 | NA | NA | 0 |
Long-Term Debt | NA | 1,752 | 1,718 | 1,367 | 1,495 |
Non-Current Capital Leases | NA | 141 | 151 | 173 | 184 |
Other Non-Current Liabilities | NA | 118 | 115 | 120 | |
Minority Interest (Liabilities) | NA | 0 | NA | NA | 0 |
Total Liabilities | NA | 3,586 | 3,313 | 3,256 | 3,258 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | NA | NA | 0 |
Common Stock (Par) | NA | 170 | 168 | 170 | 173 |
Capital Surplus | NA | 217 | 207 | 207 | 222 |
Retained Earnings | NA | 2,210 | 2,412 | 2,383 | 2,373 |
Other Equity | NA | 304 | 244 | 278 | 281 |
Treasury Stock | NA | 121 | 480 | 350 | 168 |
Total Shareholder's Equity | NA | 2,781 | 2,551 | 2,689 | 2,881 |
Total Liabilities & Shareholder's Equity | NA | 6,367 | 5,864 | 5,944 | 6,140 |
Total Common Equity | 0 | 2,781 | 102,550 | 102,688 | 2,881 |
Shares Outstanding | 581.20 | 580.80 | 594.10 | 594.10 | 594.10 |
Book Value Per Share | 0.00 | 4.79 | 172.61 | 172.85 | 4.85 |